jamunjar-logo
whatsapp
cartmembermenu
Search for
"test & packages"
"physiotherapy"
"heart"
"lungs"
"diabetes"
"kidney"
"liver"
"cancer"
"thyroid"
"bones"
"fever"
"vitamin"
"iron"
"HTN"

Silver (Blood)

Hormone/ Element
image

Report in 12Hrs

image

At Home

nofastingrequire

No Fasting Required

Details

Detects silver exposure.

7031,004

30% OFF

Silver (Blood) - Comprehensive Test Information Guide

  • Why is it done?
    • Measures circulating silver levels in blood serum to assess exposure or accumulation in the body
    • Evaluates for argyrosis (abnormal skin pigmentation due to silver deposition) and systemic silver toxicity
    • Monitors occupational exposure in workers handling silver compounds, jewelry makers, or those in manufacturing industries
    • Assesses complications from prolonged use of colloidal silver supplements or alternative medicine preparations
    • Investigates suspected silver poisoning or overdose situations
    • Evaluates patients with unexplained hyperpigmentation, neurological symptoms, or kidney dysfunction with suspected silver exposure
    • Typically performed when clinical symptoms suggestive of chronic silver exposure or toxicity are present
  • Normal Range
    • Normal/Reference Values: Less than 0.5 mcg/L (or < 5 ng/mL in some labs)
    • Units of Measurement: mcg/L (micrograms per liter) or ng/mL (nanograms per milliliter)
    • Interpretation: Normal/Negative: < 0.5 mcg/L indicates no clinically significant silver accumulation
    • Elevated/Positive: > 0.5 mcg/L may indicate exposure or accumulation; levels > 1.0 mcg/L warrant clinical concern
    • Borderline/Gray Zone: 0.5-1.0 mcg/L may require clinical correlation and repeat testing
    • Very High Levels: > 10 mcg/L generally indicates significant chronic exposure or acute poisoning requiring medical intervention
    • Note: Reference ranges may vary slightly between laboratories; always refer to the specific lab's reference range provided with results
  • Interpretation
    • Low/Normal Results (< 0.5 mcg/L): Indicate no significant silver accumulation or exposure; patient is within safe limits for silver exposure
    • Mildly Elevated Results (0.5-2.0 mcg/L): Suggest mild chronic exposure or early silver accumulation; may warrant discontinuation of colloidal silver use and repeat testing in 3-6 months
    • Moderately Elevated Results (2.0-10.0 mcg/L): Indicate significant exposure or accumulation; increased risk for argyrosis and systemic toxicity; immediate cessation of silver exposure recommended; consideration for chelation therapy may be warranted
    • Markedly Elevated Results (> 10.0 mcg/L): Suggest severe exposure or acute poisoning; requires urgent medical intervention, investigation of source, supportive care, and possible chelation therapy
    • Factors Affecting Results: Occupational exposure (jewelry making, manufacturing, plating); duration and intensity of exposure; use of colloidal silver supplements; contaminated dietary sources; collection tube contamination; medication interactions; individual metabolism and absorption rates
    • Clinical Significance: Elevated silver levels correlate with risk of argyrosis (blue-gray skin discoloration), neurological effects (tremors, cognitive changes), renal dysfunction, and argyria; levels must be correlated with clinical symptoms and exposure history
  • Associated Organs
    • Primary Organ Systems Involved: Integumentary system (skin); central nervous system; kidneys; liver; gastrointestinal tract; lymphatic system
    • Conditions Associated with Elevated Silver: Argyrosis (reversible blue-gray skin discoloration); Argyria (permanent gray-blue pigmentation); nephrotic syndrome; acute kidney injury; hepatotoxicity; neurological disorders (tremors, cognitive dysfunction); contact dermatitis; photosensitivity reactions
    • Diseases/Conditions Diagnosed or Monitored: Chronic silver poisoning; acute silver toxicity; occupational silver exposure; colloidal silver supplement toxicity; environmental contamination exposure; metal metabolism disorders
    • Potential Complications from Elevated Levels: Renal impairment or failure; hepatic dysfunction; neurological sequelae including Parkinson's-like symptoms; reduced antimicrobial immunity; premature aging of skin; ocular involvement (corneal and lens changes); systemic inflammation; potential mutagenic or carcinogenic effects at extreme levels
  • Follow-up Tests
    • Recommended Based on Elevated Results: Comprehensive metabolic panel (kidney and liver function); urinalysis and 24-hour urine collection (to assess renal excretion); complete blood count; creatinine clearance assessment
    • Further Investigations: Urine silver levels; hair or tissue silver analysis (for chronic exposure assessment); skin biopsy if argyrosis suspected; neuropsychological testing if cognitive changes present; ophthalmological examination; imaging studies as clinically indicated
    • Monitoring Schedule: For ongoing occupational exposure: annually or per regulatory requirements; for documented silver intake: repeat testing 3-6 months after exposure cessation; during chelation therapy: weekly or as per protocol; for baseline: every 1-2 years if occupational risk continues
    • Complementary Tests: Other heavy metal screening (lead, mercury, cadmium); ceruloplasmin (copper metabolism); serum albumin; prealbumin; vitamin levels if absorption issues present; thyroid function tests; immunological markers
  • Fasting Required?
    • Fasting Requirement: No, fasting is NOT required for the silver blood test
    • Patient Preparation Instructions: Patient may eat and drink normally before the test; no overnight fasting required; test can be performed at any time of day; normal daily activities may continue
    • Important Considerations: Avoid contamination of the collection site; ensure proper skin antisepsis prior to venipuncture using non-silver-containing antiseptics (alcohol-based); use appropriate collection tubes (certified metal-free); remove jewelry from the arm being sampled if possible
    • Medications: Most medications do not require discontinuation; however, discontinue colloidal silver supplements 24-48 hours prior to testing if assessing baseline levels; if on chelation therapy, coordinate timing with test scheduling; inform provider of all supplements and medications
    • Special Instructions: Inform phlebotomist of suspected or confirmed silver exposure; specify source and duration of exposure; note any current symptoms of silver toxicity; document current supplement or medication use; wear loose-fitting clothing for easy arm access

How our test process works!

customers
customers